Stockscreener 앱 받기
4.00
6.54%
-0.28
전일 마감가:
$4.28
열려 있는:
$4.15
하루 거래량:
68,159
Relative Volume:
0.15
시가총액:
$3.41M
수익:
$743.00K
순이익/손실:
$-7.63M
주가수익비율:
-1.3333
EPS:
-3
순현금흐름:
-
1주 성능:
-3.38%
1개월 성능:
-30.80%
6개월 성능:
-80.86%
1년 성능:
-87.42%
1일 변동 폭
$3.95
$4.2911
1주일 범위
$3.95
$4.425
52주 변동 폭
$3.356
$46.60
캔 파이트 바이오파마 Stock (CANF) Company Profile
명칭
Can-Fite Biopharma Ltd ADR
전화
972 3 924 1114
주소
10 Bareket Street, Kiryat Matalon PO Box 7537, Petah-Tikva
CANF을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CANF
Can-Fite Biopharma Ltd ADR
|
4.00 | 3.65M | 743.00K | -7.63M | 0 | -3.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
캔 파이트 바이오파마 Stock (CANF) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2017-08-11 | 개시 | Maxim Group | Buy |
| 2016-10-19 | 재개 | ROTH Capital | Buy |
| 2016-08-29 | 재개 | Rodman & Renshaw | Buy |
| 2015-11-30 | 재확인 | H.C. Wainwright | Buy |
| 2015-03-31 | 재확인 | H.C. Wainwright | Buy |
| 2015-03-30 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-29 | 재확인 | ROTH Capital | Buy |
| 2014-11-18 | 개시 | H.C. Wainwright | Buy |
모두보기
캔 파이트 바이오파마 주식(CANF)의 최신 뉴스
Published on: 2026-01-10 23:44:28 - ulpravda.ru
CANF Stock Price, Forecast & Analysis | CAN FITE BIOPHARMA LTD-ADR (NYSEARCA:CANF) - Chartmill
Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Benzinga
Can Fite Biopharma stock soars on Brazil patent grant for sexual dysfunction - Investing.com
Can Fite Biopharma stock soars on Brazil patent grant for sexual dysfunction By Investing.com - Investing.com South Africa
Can-Fite Biopharma Ltd Sponsored ADR (Israel) (NYSE:CANF) Stock Quote - FinancialContent
Can-Fite BioPharma stock rating downgraded to Hold by D. Boral Capital - Investing.com South Africa
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm
Why Multi Ways Holdings Shares Are Trading Higher By Around 60%; Here Are 20 Stocks Moving Premarket - Sahm
UiPath, Ramaco Resources And 3 Stocks To Watch Heading Into Wednesday - Sahm
NYSE AMEX Composite Index (XAX) - Investing.com Canada
Can Fite Biopharma stock tumbles after announcing 1-for-3,000 reverse split By Investing.com - Investing.com South Africa
Can Fite Biopharma stock tumbles after announcing 1-for-3,000 reverse split - Investing.com India
Can-Fite BioPharma announces 1-for-3,000 reverse stock split - Investing.com
Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change - GlobeNewswire Inc.
Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change - Sahm
Can Can Fite Biopharma Ltd Sponsored ADR stock ride next bull market cycleMarket Rally & Community Verified Trade Signals - Улправда
EBITDA per share of Can-Fite BioPharma Ltd. Sponsored ADR – AMEX:CANF - TradingView — Track All Markets
AST SpaceMobile Inc (ASTS) can make a big difference with a little luck - setenews.com
Can Can Fite Biopharma Ltd Sponsored ADR stock survive global slowdown2025 Price Momentum & AI Based Trade Execution Alerts - Newser
Will Can Fite Biopharma Ltd Sponsored ADR stock see insider accumulation2025 Fundamental Recap & Daily Technical Forecast Reports - Newser
Can Can Fite Biopharma Ltd Sponsored ADR stock sustain breakout momentum2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
Can Can Fite Biopharma Ltd Sponsored ADR stock test all time highsMarket Performance Report & Free Expert Approved Momentum Trade Ideas - Newser
How big funds are accumulating Can Fite Biopharma Ltd Sponsored ADR stockDividend Hike & AI Enhanced Trade Execution Alerts - Newser
Is Can Fite Biopharma Ltd Sponsored ADR stock positioned for secular growth2025 Key Lessons & Growth Focused Entry Reports - Newser
Can Can Fite Biopharma Ltd Sponsored ADR stock deliver double digit returnsJuly 2025 Short Interest & Fast Moving Stock Watchlists - Newser
An analyst sees good growth prospects for Can-Fite Biopharma Ltd ADR (CANF) - Setenews
Can-Fite’s Latest Developments of its Advanced Stage Drug Pipeline will be Presented at Noble Capital Markets 21st Annual Emerging Growth Equity Conference - Sahm
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
You might want to take a look at Pasithea Therapeutics Corp (KTTA) now - Setenews
Can-Fite to Advance New Veterinary Partnership Opportunities for Namodenoson at the BioFIT 2025 Conference - The Manila Times
Can-Fite’s CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil - Sahm
Will Can Fite Biopharma Ltd Sponsored ADR stock beat revenue estimatesQuarterly Performance Summary & Scalable Portfolio Growth Ideas - newser.com
Why Can Fite Biopharma Ltd Sponsored ADR stock is a strong analyst pickJuly 2025 Intraday Action & Capital Efficient Trading Techniques - newser.com
Can Can Fite Biopharma Ltd Sponsored ADR stock expand revenue streams - newser.com
Take off with Santech Holdings Ltd. ADR (STEC): Get ready for trading - Setenews
How does Can-Fite Biopharma Ltd ADR (CANF) change from a tortoise to a hare? - Setenews
Can-Fite BioPharma (NYSE American: CANF) reports 9-year Namodenoson response in HCC - Stock Titan
캔 파이트 바이오파마 (CANF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):